Lenalidomide Maintenance Therapy after Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Multiple Myeloma Patients: Factors That Impact Treatment
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.5416.5416
Abstract: Introduction Maintenance therapy after an Autologous PBSCT remains the standard of care in patients with Multiple Myeloma, having been shown to increase progression free survival, and based on the CALGB study, overall survival. Accordingly, Lenalidomide… read more here.
Keywords: lenalidomide maintenance; maintenance therapy; maintenance; autologous pbsct ... See more keywords